Molecular pathology of head-and-neck cancer

Michael Kim, Joseph A. Califano

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Each year approximately 40,000 people in the United States and 500,000 people worldwide are diagnosed with head-and-neck squamous cell carcinoma (HNSC). Although there have been significant improvements in the treatment of this disease, leading to decreased morbidity, over the past few decades the 5-year survival rate has remained largely unchanged at 50%. Genetic and epigenetic alterations as well as viral agents have been implicated in the development of head-and-neck cancer. Advances in our understanding of the molecular biology underlying these processes have spawned numerous, diverse strategies to exploit this understanding in applied pathology. Preliminary investigations have analyzed body fluids and margins for the presence of cancer cells. Specific molecular alterations have been associated with improved treatment response and prognosis. Molecular therapy has been shown to have some clinical efficacy in HNSC. Expression profiles may be generated for specific primary tumors and compared to known markers of disease. Improved molecular characterization of primary tumors, surgical margins and body fluids may allow clinicians to detect and treat earlier lesions, predict a tumor's response to treatment, tailor treatment to specific molecular alterations and ultimately improve clinical outcomes related to HNSC.

Original languageEnglish (US)
Pages (from-to)545-553
Number of pages9
JournalInternational Journal of Cancer
Volume112
Issue number4
DOIs
StatePublished - Nov 20 2004
Externally publishedYes

Fingerprint

Molecular Pathology
Head and Neck Neoplasms
Body Fluids
Neoplasms
Epigenomics
Molecular Biology
Survival Rate
Pathology
Morbidity
Carcinoma, squamous cell of head and neck
Therapeutics

Keywords

  • Head-and-neck cancer
  • Molecular pathology
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Molecular pathology of head-and-neck cancer. / Kim, Michael; Califano, Joseph A.

In: International Journal of Cancer, Vol. 112, No. 4, 20.11.2004, p. 545-553.

Research output: Contribution to journalArticle

Kim, Michael ; Califano, Joseph A. / Molecular pathology of head-and-neck cancer. In: International Journal of Cancer. 2004 ; Vol. 112, No. 4. pp. 545-553.
@article{f66e384245dc4b1fb668cf5d34cbb717,
title = "Molecular pathology of head-and-neck cancer",
abstract = "Each year approximately 40,000 people in the United States and 500,000 people worldwide are diagnosed with head-and-neck squamous cell carcinoma (HNSC). Although there have been significant improvements in the treatment of this disease, leading to decreased morbidity, over the past few decades the 5-year survival rate has remained largely unchanged at 50{\%}. Genetic and epigenetic alterations as well as viral agents have been implicated in the development of head-and-neck cancer. Advances in our understanding of the molecular biology underlying these processes have spawned numerous, diverse strategies to exploit this understanding in applied pathology. Preliminary investigations have analyzed body fluids and margins for the presence of cancer cells. Specific molecular alterations have been associated with improved treatment response and prognosis. Molecular therapy has been shown to have some clinical efficacy in HNSC. Expression profiles may be generated for specific primary tumors and compared to known markers of disease. Improved molecular characterization of primary tumors, surgical margins and body fluids may allow clinicians to detect and treat earlier lesions, predict a tumor's response to treatment, tailor treatment to specific molecular alterations and ultimately improve clinical outcomes related to HNSC.",
keywords = "Head-and-neck cancer, Molecular pathology, Squamous cell carcinoma",
author = "Michael Kim and Califano, {Joseph A.}",
year = "2004",
month = "11",
day = "20",
doi = "10.1002/ijc.20379",
language = "English (US)",
volume = "112",
pages = "545--553",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Molecular pathology of head-and-neck cancer

AU - Kim, Michael

AU - Califano, Joseph A.

PY - 2004/11/20

Y1 - 2004/11/20

N2 - Each year approximately 40,000 people in the United States and 500,000 people worldwide are diagnosed with head-and-neck squamous cell carcinoma (HNSC). Although there have been significant improvements in the treatment of this disease, leading to decreased morbidity, over the past few decades the 5-year survival rate has remained largely unchanged at 50%. Genetic and epigenetic alterations as well as viral agents have been implicated in the development of head-and-neck cancer. Advances in our understanding of the molecular biology underlying these processes have spawned numerous, diverse strategies to exploit this understanding in applied pathology. Preliminary investigations have analyzed body fluids and margins for the presence of cancer cells. Specific molecular alterations have been associated with improved treatment response and prognosis. Molecular therapy has been shown to have some clinical efficacy in HNSC. Expression profiles may be generated for specific primary tumors and compared to known markers of disease. Improved molecular characterization of primary tumors, surgical margins and body fluids may allow clinicians to detect and treat earlier lesions, predict a tumor's response to treatment, tailor treatment to specific molecular alterations and ultimately improve clinical outcomes related to HNSC.

AB - Each year approximately 40,000 people in the United States and 500,000 people worldwide are diagnosed with head-and-neck squamous cell carcinoma (HNSC). Although there have been significant improvements in the treatment of this disease, leading to decreased morbidity, over the past few decades the 5-year survival rate has remained largely unchanged at 50%. Genetic and epigenetic alterations as well as viral agents have been implicated in the development of head-and-neck cancer. Advances in our understanding of the molecular biology underlying these processes have spawned numerous, diverse strategies to exploit this understanding in applied pathology. Preliminary investigations have analyzed body fluids and margins for the presence of cancer cells. Specific molecular alterations have been associated with improved treatment response and prognosis. Molecular therapy has been shown to have some clinical efficacy in HNSC. Expression profiles may be generated for specific primary tumors and compared to known markers of disease. Improved molecular characterization of primary tumors, surgical margins and body fluids may allow clinicians to detect and treat earlier lesions, predict a tumor's response to treatment, tailor treatment to specific molecular alterations and ultimately improve clinical outcomes related to HNSC.

KW - Head-and-neck cancer

KW - Molecular pathology

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=7044224639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7044224639&partnerID=8YFLogxK

U2 - 10.1002/ijc.20379

DO - 10.1002/ijc.20379

M3 - Article

C2 - 15382034

AN - SCOPUS:7044224639

VL - 112

SP - 545

EP - 553

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -